Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-23

Clinical Trial Update: Chinese Atrial Fibrillation Registry

View source ↗

Summary

The clinical trial registry entry shows ongoing recruitment for the Chinese Atrial Fibrillation Registry sponsored by Beijing Anzhen Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Atrial Fibrillation (AF) | Status: RECRUITING